RYTM
Rhythm Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$102.80
−2.00%Margins
Gross margin
89.0%
EBITDA margin
-77.0%
EBIT margin
-83.6%
Net margin
-85.6%
FCF margin
-62.7%
-94.5%
Return on equity
-47.0%
Return on assets
-90.8%
Return on invested capital
0.55x
Asset turnover
-$149.5M
Cash from operations
$4.81
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026